Ultragenyx Pharmaceutical shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Ultragenyx Pharmaceutical
Tip: Access up to 7 years of quarterly data
All positions including Ultragenyx Pharmaceutical held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ultragenyx Pharmaceutical by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $4.1M | 87k | 47.82 |
| 2023-09-30 | $6.5M | 182k | 35.65 |
| 2023-06-30 | $9.5M | 206k | 46.13 |
| 2023-03-31 | $8.3M | 208k | 40.10 |
| 2022-12-31 | $11M | 230k | 46.33 |
| 2022-09-30 | $7.8M | 188k | 41.41 |
| 2022-06-30 | $1.9M | 33k | 59.67 |
| 2021-06-30 | $225k | 2.4k | 95.46 |
| 2021-03-31 | $1.8M | 16k | 113.86 |
| 2020-12-31 | $364k | 2.6k | 138.61 |
| 2015-06-30 | $389k | 3.8k | 102.37 |
| 2015-03-31 | $417k | 5.3k | 78.68 |
| 2014-12-31 | $213k | 4.2k | 50.71 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management